HIV

GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
GSK
R&D
COPD
HIV
cancer
Flag link:
CytoDyn shares slammed as BLA filing for leronlimab in HIV hits a wall
CytoDyn shares slammed as BLA filing for leronlimab in HIV hits a wall
Endpoints
CytoDyn
leronlimab
HIV
FDA
Flag link:
After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure
After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure
Endpoints
Merck
Dewpoint Therapeutics
HIV
R&D
Flag link:
GSK sets the stage for a toe-to-toe market showdown with Gilead's HIV champion Truvada
GSK sets the stage for a toe-to-toe market showdown with Gilead's HIV champion Truvada
Endpoints
GSK
Gilead Sciences
ViiV Healthcare
HIV
cabotegravir
Truvada
Flag link:
GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options
GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options
Fierce Pharma
GSK
ViiV Healthcare
Rukobia
fostemsavir
HIV
FDA
Flag link:
ViiV Healthcare gets FDA nod for HIV drug Rukobia to treat adult patients
ViiV Healthcare gets FDA nod for HIV drug Rukobia to treat adult patients
Pharmaceutical Business Review
ViiV Healthcare
FDA
Rukobia
HIV
Flag link:
New Data Shows Promise Involving Lenacapavir for the Treatment of HIV
New Data Shows Promise Involving Lenacapavir for the Treatment of HIV
BioSpace
Gilead Sciences
lenacapavir
HIV
Flag link:
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Stat
HIV
Gilead Sciences
lenacapavir
clinical trials
Flag link:
Large UK study finds no benefit to HIV antiviral in COVID-19
Large UK study finds no benefit to HIV antiviral in COVID-19
BioPharma Dive
HIV
antivirals
COVID-19
pandemic
Kaletra
AbbVie
Flag link:
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
BioSpace
Merck
vaccines
V114
clinical trials
HIV
pneumonia
pneumococcal disease
Flag link:
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Motley Fool
Gilead Sciences
HIV
bNab
Flag link:
Life-Saving HIV Drug PrEP On NHS Delayed Amid Coronavirus Pandemic
Life-Saving HIV Drug PrEP On NHS Delayed Amid Coronavirus Pandemic
Forbes
HIV
NHS
PrEP
pandemic
COVID-19
Flag link:
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
BioSpace
ImmunityBio
HIV
clinical trials
N-803
Flag link:
GSK sub’s injectable outperforms Gilead in late-stage PrEP trial
GSK sub’s injectable outperforms Gilead in late-stage PrEP trial
Endpoints
GSK
Gilead Sciences
HIV
PrEP
Truvada
ViiV Healthcare
cabotegravir
Flag link:
More threat to Gilead's HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada
More threat to Gilead's HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada
Fierce Pharma
GSK
Gilead Sciences
Truvada
cabotegravir
HIV
PrEP
Flag link:
Gilead charges CDC with contract breach on HIV research
Gilead charges CDC with contract breach on HIV research
Seeking Alpha
Gilead Sciences
CDC
patents
lawsuits
HIV
R&D
Flag link:
HIV And Flu Drugs Prove Futile In Fight Against Coronavirus
HIV And Flu Drugs Prove Futile In Fight Against Coronavirus
Forbes
China
clinical trials
HIV
Kaletra
Arbidol
COVID-19
Flag link:
J&J HIV drug already in Covid-19 clinical trials flunks in vitro study
J&J HIV drug already in Covid-19 clinical trials flunks in vitro study
MedCity News
JNJ
COVID-19
clinical trials
Prezista
HIV
Flag link:
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
Fierce Pharma
ACC
Repatha
HIV
clinical trials
Amgen
Flag link:
AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report
AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report
Fierce Pharma
AbbVie
HIV
Kaletra
patents
COVID-19
Flag link:

Pages